2型糖尿病患者のHbA1c濃度を下げるためのカウンセリング介入の有効性:モデル研究
Mohammed B Sarhan1, Rula Ghandour1, Niveen M E Abu Rmeileh1
1Institute of Community and Public Health, Birzeit University, Birzeit, West Bank, occupied Palestinian territory.
Lancet (London, England)
|March 20, 2018
まとめ
この研究では,ショートメッセージサービス (SMS) による介入が2型糖尿病のコントロールを改善するのに最も効果的であることが判明しました. これらの低コストな プライマリケア介入を 実施することで パレスチナの HbA1c レベルと 糖尿病の合併症を 減らすことができます
科学分野:
- 公衆衛生
- 糖尿病 管理
- 医療サービス研究
背景:
- 2型糖尿病は,占領下のパレスチナの健康上の課題として増大しています.
- 効果的な血糖制御 (HbA1c) は,糖尿病に関連する合併症の予防に不可欠です.
- 2型糖尿病の管理のために,様々なカウンセリングの介入が世界中で検討されています.
研究 の 目的:
- 2型糖尿病患者の血糖制御を改善するために,さまざまな初等保健レベルのカウンセリング介入の有効性を評価する.
- パレスチナの保健医療システムに 低コストで実行可能で受け入れられる介入を 特定する.
主な方法:
- 2型糖尿病患者を対象としたカウンセリングの介入は,文献のレビューによって,初等保健レベルで特定されました.
- WHOの"ベスト・バイ"の基準に基づいて介入が選択され,実現可能性と受け入れが考慮された.
- HbA1c濃度の低下における各介入の効果 (非標準化β係数) を推定するために,回帰分析を使用した.
主要な成果:
- 3つの効果的なカウンセリング介入が特定されました 個別カウンセリング,地域保健医療従事者の家庭訪問,短メッセージサービス (SMS) によるカウンセリングです
- すべての介入は平均HbA1c濃度を下げるのに有効であることが示された.
- SMSベースの介入は最も高い効果を示した (β=0·65),次に地域保健医療従事者の介入 (β=0·27) と個人カウンセリング (β=0·14) が続いた.
結論:
- SMSベースのカウンセリングのような費用対効果の高いプライマリケア介入の実施は,2型糖尿病患者の血糖制御を大幅に改善することができます.
- これらの介入は,糖尿病の合併症の流行を減らす可能性があり,パレスチナの医療制度の経済的負担を軽減します.
- この発見は,選択された"ベスト・バイ"の介入を,より良い糖尿病管理のためにパレスチナの保健医療システムに統合することを支持しています.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Radical Reactivity: Concentration Effects
1.9K
In a radical reaction, the concentration of starting materials governs the selectivity of a radical. For example, the reaction between an alkyl halide and an alkene, in the presence of tin hydride and AIBN, begins with the generation of a tin radical. The generated radical then abstracts halogen from the alkyl halide, producing an alkyl radical. This alkyl radical can either react with tin hydride, yielding an alkane, or add to an alkene, generating a nitrile-stabilized radical, eventually...
1.9K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Pharmacodynamics in Geriatric Patients: Effects of Age
241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacodynamic Models: Linear Concentration–Effect Model
2
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing...
2
Pharmacodynamic Models: Logarithmic Concentration–Effect Model
1
The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration,...
1


